Northern Trust Corp Royalty Pharma PLC Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Northern Trust Corp holds 2,953,810 shares of RPRX stock, worth $71.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,953,810

Previous 3,297,277 10.42%

Holding current value

$71.7 Million

Previous $86.9 Million 3.89%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$25.63 - $29.27 $8.8 Million - $10.1 Million	-343,467 Reduced 10.42%	2,953,810 $83.6 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $12.7 Million - $14.5 Million	484,144 Added 17.21%	3,297,277 $86.9 Million
Q1 2024 May 14, 2024	BUY	$27.46 - $31.33 $4.91 Million - $5.61 Million	178,958 Added 6.79%	2,813,133 $85.4 Million
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $949,483 - $1.06 Million	36,226 Added 1.39%	2,634,175 $74 Million
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $5.89 Million - $7.04 Million	224,261 Added 9.45%	2,597,949 $70.5 Million
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $3.08 Million - $3.8 Million	-104,040 Reduced 4.2%	2,373,688 $73 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $1.58 Million - $1.9 Million	48,275 Added 1.99%	2,477,728 $89.3 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $3.09 Million - $3.47 Million	78,769 Added 3.35%	2,429,453 $96 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $1.29 Million - $1.44 Million	-32,350 Reduced 1.36%	2,350,684 $94.5 Million
Q2 2022 Aug 12, 2022	SELL	$37.53 - $44.22 $962,644 - $1.13 Million	-25,650 Reduced 1.06%	2,383,034 $100 Million
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $5.51 Million - $6.24 Million	147,062 Added 6.5%	2,408,684 $93.8 Million
Q4 2021 Feb 08, 2022	BUY	$35.17 - $42.48 $20.9 Million - $25.2 Million	592,948 Added 35.53%	2,261,622 $90.1 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $16.3 Million - $19 Million	450,183 Added 36.95%	1,668,674 $60.3 Million
Q2 2021 Aug 13, 2021	SELL	$39.85 - $46.63 $3.47 Million - $4.06 Million	-87,142 Reduced 6.67%	1,218,491 $49.9 Million
Q1 2021 May 12, 2021	BUY	$42.34 - $52.82 $23.6 Million - $29.5 Million	558,274 Added 74.7%	1,305,633 $57 Million
Q4 2020 Feb 11, 2021	BUY	$36.12 - $50.05 $7.13 Million - $9.88 Million	197,318 Added 35.87%	747,359 $37.4 Million
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $15.1 Million - $18.9 Million	391,165 Added 246.21%	550,041 $23.1 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $7.07 Million - $8.28 Million	158,876 New	158,876 $7.71 Million

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Royalty Pharma PLC Transaction History